The human erythrocyte travels nearly 300 miles through 170,000 circuits of the circulatory system during its 120-day lifespan. This prolonged voyage subjects the red cell membrane to high and varied shear forces, to compression and stretching when traversing sinusoidal capillary beds, to osmotic shrinkage and swelling when passing through the renal medulla, to oxidative stress during repeated cycles of deoxygenation and re-oxygenation, to assault from the complement system, and to gradual loss of surface area from microvesicle shedding and from macrophage-mediated erythrophagocytosis. Volume regulatory ion transport systems help red cells adapt to these demands, and the transporters and channels that regulate red cell volume are controlled, at least in part, by membrane mechanosensors, including the cation channel, PIEZO1.1 Gain-of-function mutations in PIEZO1 cause autosomal dominant dehydrated stomatocytosis (DHSt), also known as xerocytosis, characterized by increased cell volume and Na content, decreased K content, and elevated MCHC,42 with often fully compensated anemia. The PIEZO1 mutants characterized to date in DHSt patients have been associated with delayed inactivation after channel opening.5 Piezo1 loss-of-function in the mouse is lethal at mid-gestation due to defective vasculogenesis,76 so the role of PIEZO1 in the mature circulating erythrocyte cannot be studied in the Piezo1 global knockout mouse.
Morpholino-knockdown of Piezo1 expression in the zebrafish (Danio rerio) was reported to result in severe anemia, as evidenced by near absence of o-dianisidine staining of 2-day post-fertilization (dpf) embryonic yolk sac and by a 60% reduction in estimated red cell number at 3 dpf. Surviving red cells were noted to be swollen and spherocytic, fragile and dysmorphic.8 The evidence supporting the specificity of piezo1 knockdown in generation of the anemic phenotype reported by Faucherre et al.8 was strengthened by reproduction of the observation in three different zebrafish strains using two different piezo1 morpholinos. The effective working doses of morpholino oligomers were titrated to maintain absence of gross developmental defects. These rather high doses injected at the one-cell stage were 8 ng for translation-blocking MO1 (complementary to the piezo1 start codon) and 10 ng for splice-blocking MO2 (complementary to the intron 1/exon 2 splice site). In addition, combined injection of the individually ineffective doses of 4 ng MO1 and 5 ng MO2 decreased embryonic yolk sac hemoglobinization, further supporting a specific effect of piezo1 knockdown.
However, recent reports have highlighted substantial differences between the zebrafish phenotypes produced by morpholino oligomer knockdowns and the phenotypes of genomic inactivation of the same genes in as many as 80% of the genes examined.119 In particular, a morpholino knockdown of piezo1 in zebrafish expressed a phenotype of fin blistering and defective gastrulation that was reasonably interpreted as supporting a role for Piezo1 in maintenance of the ability of epithelial monolayers at steady state to extrude dying cells.12 However, the fin blistering phenotype was not present in an independent zebrafish line carrying a zinc finger (ZFN)-induced 5 nt deletion in the piezo1 gene, encoding a predicted frameshift in piezo1 exon 8, followed by termination in early exon 9.9 The erythroid phenotype of that piezo1−/− strain was not investigated in that work.
We have now examined the erythroid phenotype in this zebrafish strain carrying a ZFN genomic knockout of piezo1. Genotyping was performed as previously described.9 In contrast to the anemic phenotype observed in zebrafish subjected to morpholino knockdown of piezo,81 the genomic ZFN knockout of piezo1 did not segregate either with anemia in the 3-dpf embryo or with dysmorphic erythrocyte morphology in the adult fish.
As shown by o-dianisidine staining of embryonic yolk sac for one clutch of zebrafish progeny arising from the mating of two piezo1+/ parents (Figure 1), normal hemoglobinization was uniformly evident among 41 embryos in a near Mendelian distribution of piezo1 genotypes among piezo1−/− (homozygous knockouts, 19.5%), piezo1+/ (heterozygote knockouts, 65.9%), and piezo1 (WT, 14.6%).
cDNA sequencing of pooled embryos confirmed that the ZFN mutant piezo1 allele is transcribed (Figure 2A). The previously reported ZFN-induced genomic lesion indeed produced the expected exon 8 frameshift in the transcribed piezo1 mRNA, encoding the missense frameshift piezo1 mutant polypeptide, DS349L350fs355X. The frame-shifted sequence continues for 7 residues of neo-sequence before encountering an out-of-frame nonsense codon early in exon 9. The presence of this identical mutation was documented by sequencing in multiple individual embryos and adults of piezo1−/− genotype. To exclude compensatory exon-skipping in the ZFN mutant fish that might have rescued expression of (modified) Piezo1 polypeptide (encoding in its wild-type form a complex polytopic membrane protein of 2538 aa), we performed RT-PCR with pooled embryo RNA to amplify and sequence piezo1 cDNA fragments. The amplicons encompass piezo1 exons 7–11, 7–16, and 7–22 (Figure 2B) and exons 42–51 (data not shown). Amplicon lengths from piezo1−/− and piezo1 genotypes were indistinguishable, and the exon 7–11 amplicon sequences revealed no additional mutations downstream of the ZFN-induced deletion mutation. (Oligonucleotide sequences are available upon request). These results demonstrate the absence of detectable exon skipping or intron retention between exons 7–22 and between exons 42–51 in the setting of the 5 bp deletion in the ZFN knockout allele. The data allow a further conclusion to be drawn that open reading frame restoration does not occur before M438 in exon 11 of the mutant piezo1 mRNA. Semi-quantitative RT-PCR (27–29 cycles, n=12) revealed mutant PIEZO1 transcript levels 35.0+1.7% of wild-type levels, consistent with a modest degree of nonsense-mediated decay.
Faucherre et al. reported in their piezo1 morphants an erythroid phenotype of fragile, spherocytic, dysmorphic cells characterized by occasional uniform attenuation, blurring, and occasional disruption of the equatorial microtubule ring that characterizes fish red cells.8 However, Figure 3 shows the normal appearance of peripheral smears of circulating red cells obtained from adult piezo1 and piezo1/ zebrafish, without evidence of spherocytosis or dysmorphic changes. The x-y dimensions of WT and knockout adult erythrocytes were subjected to image analysis, as described previously.1413 The calculated aspect ratios of the elliptical adult red cells from piezo1 (n=634) and piezo1/ fish (n=764) were indistinguishable at 1.40 (P>0.1). The cross-sectional area of piezo1/ red cells was 7.6% less than that of piezo1 red cells, inconsistent with the increased cell volume previously reported in the piezo1 morphants.8 The reasons for the lack of agreement between the erythroid phenotypes of reported zebrafish piezo1 morphants8 and the ZFN knockout of piezo19 are unclear. Possible considerations include use in the morphant experiments of uninjected embryos as negative controls, rather than embryos injected with scrambled or sense morpholinos. In addition, the fraction of total injected embryos represented by embryos that showed the anemic phenotype was not reported, and piezo1 rescue of the anemic phenotype was not presented.
The 25 nt piezo1 morpholinos,8 MO1 and MO2, are not predicted to interfere with transcription or splicing of the four currently annotated piezo2-like genes. However, MO1 also shares perfect matches over 15 contiguous nt with predicted exonic sequences in ogt1 (GlcNAc transferase), rhbd12 (rhomboid protease), and LOC101886676 (encoding an HMG domain protein), and so may be non-specific at the relatively high dose of 8 ng. MO2 also perfectly matches sequences of 16–19 nt in length found in nearly all zebrafish linkage groups, as well as in exons of vegfc, ttna, and ttnb. Thus, the modest 50% reduction in exon 1–2 splicing of piezo1 mRNA produced by 10 ng MO2 may be non-specific.
Of course, provisos also apply to the non-anemic phenotype of the ZFN knockout. Basal exon-skipping has been proposed to be a widespread mechanism for generation of genetic pleiotropy, active even in the absence of frameshift and termination mutations.15 Thus, the mRNA transcript of the ZFN-knockout allele might undergo exon-skipping between exon 8 and a locus between exons 22 and 42, but the resulting large internal deletion probably would not encode a functional PIEZO1 polypeptide. Alternatively, piezo1 mRNA translation might undergo re-initiation at a downstream initiation codon, such as M438 in exon 11 (corresponding to mPIEZO1 L424), or at a methionine further downstream, or at an atypical translational re-initiation codon. (The functional consequences of N-terminal PIEZO1 deletions have not been reported, but deletion of the C-terminal 303 amino acid residues of human PIEZO1 prolongs channel inactivation5). Additional possible downstream rescue mechanisms include activation of cryptic slice sites, RNA editing, ribosomal frameshifting, or possible ZFN-triggered DNA repair processes that might generate additional polymorphisms such as the synonymous SNPs evident in Figure 2A. Lastly, in vivo selective pressure might up-regulate uncharacterized compensatory suppressor mutations, as recently reported.11
After completion of our studies, Cahalan et al.16 recently reported creation of a mouse line in which the Piezo1 gene underwent Cre-mediated deletion of exons 20–23 in hematopoietic cells. The resulting mice are remarkable for the absence of anemia or reticulocytosis, and their morphologically normal discoid erythrocytes are without spherocytosis. However, the discocytes are mildly macrocytic with slightly reduced MCHC and correspondingly increased susceptibility to osmotic lysis. Intravascular hemolysis was suggested by reduction in serum haptoglobin. This recently reported phenotype of mouse red cells lacking functional PIEZO1 is consistent with our observations that the ZFN-knockout of piezo1 in zebrafish is compatible with a grossly normal erythroid phenotype, without severe spherocytic anemia.
Subsequent to our submission, two recent studies have described patients with autosomal dominant lymphatic dysplasia due to homozygous loss-of-function mutations in PIEZO1. These patients exhibit asymptomatic, fully compensated mild hemolytic anemia of incomplete penetrance.1817
References
- Coste B, Mathur J, Schmidt M. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science. 2010; 330(6000):55-60. PubMedhttps://doi.org/10.1126/science.1193270Google Scholar
- Andolfo I, Alper SL, De Franceschi L. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood. 2013; 121(19):S1-12. PubMedhttps://doi.org/10.1182/blood-2013-02-482489Google Scholar
- Zarychanski R, Schulz VP, Houston BL. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood. 2012; 120(9):1908-1915. PubMedhttps://doi.org/10.1182/blood-2012-04-422253Google Scholar
- Albuisson J, Murthy SE, Bandell M. Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nat Commun. 2013; 4:1884. PubMedGoogle Scholar
- Bae C, Gnanasambandam R, Nicolai C. Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1. Proc Natl Acad Sci USA. 2013; 110(12):E1162-1168. PubMedhttps://doi.org/10.1073/pnas.1219777110Google Scholar
- Li J, Hou B, Tumova S. Piezo1 integration of vascular architecture with physiological force. Nature. 2014; 515(7526):279-282. PubMedhttps://doi.org/10.1038/nature13701Google Scholar
- Ranade SS, Qiu Z, Woo SH. Piezo1, a mechanically activated ion channel, is required for vascular development in mice. Proc Natl Acad Sci USA. 2014; 111(28):10347-10352. PubMedhttps://doi.org/10.1073/pnas.1409233111Google Scholar
- Faucherre A, Kissa K, Nargeot J. Piezo1 plays a role in erythrocyte volume homeostasis. Haematologica. 2014; 99(1):70-75. PubMedhttps://doi.org/10.3324/haematol.2013.086090Google Scholar
- Kok FO, Shin M, Ni CW. Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. Dev Cell. 2015; 32(1):97-108. PubMedhttps://doi.org/10.1016/j.devcel.2014.11.018Google Scholar
- Schulte-Merker S, Stainier DY. Out with the old, in with the new: reassessing morpholino knockdowns in light of genome editing technology. Development. 2014; 141(16):3103-3104. PubMedhttps://doi.org/10.1242/dev.112003Google Scholar
- Rossi A, Kontarakis Z, Gerri C. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature. 2015; 524(7564):230-233. PubMedhttps://doi.org/10.1038/nature14580Google Scholar
- Eisenhoffer GT, Loftus PD, Yoshigi M. Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. Nature. 2012; 484(7395):546-549. PubMedhttps://doi.org/10.1038/nature10999Google Scholar
- Thon JN, Macleod H, Begonja AJ. Microtubule and cortical forces determine platelet size during vascular platelet production. Nat Commun. 2012; 3:852. PubMedhttps://doi.org/10.1038/ncomms1838Google Scholar
- Hildick-Smith GJ, Cooney JD, Garone C. Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4. Am J Hum Genet. 2013; 93(5):906-914. PubMedhttps://doi.org/10.1016/j.ajhg.2013.09.011Google Scholar
- Drivas TG, Wojno AP, Tucher B. Basal exon skipping and genetic pleiotropy: a predictive model of disease pathogenesis. Sci Transl Med. 2015; 7(291):291ra297. Google Scholar
- Cahalan SM, Lukacs V, Ranade SS. Piezo1 links mechanical forces to red blood cell volume. Elife. 2015; 4:e07370. https://doi.org/10.7554/eLife.07370Google Scholar
- Fotiou E, Martin-Almedina S, Simpson MA. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015; 6:8085. PubMedhttps://doi.org/10.1038/ncomms9085Google Scholar
- Lukacs V, Mathur J, Mao R. Impaired PIEZO1 function in patients with a novel autosomal recessive congenital lymphatic dysplasia. Nat. Commun. 2015; 6:8329. PubMedhttps://doi.org/10.1038/ncomms9329Google Scholar